Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

G0/G1 Cell Cycle Arrest and Activation of Caspases in Honokiol-mediated Growth Inhibition of Human Gastric Cancer Cells

  • Received : 2012.01.19
  • Accepted : 2012.02.29
  • Published : 2012.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Honokiol, a naturally occurring neolignan mainly found in Magnolia species, has been shown to have the anti-angiogenic, anti-invasive and cancer chemopreventive activities, but the molecular mechanism of actions has not been fully elucidated yet. In the present study, we investigated the effect of honokiol on the growth inhibitory activity in cultured SNU-638 human gastric cancer cells. We found that honokiol exerted potent antiproliferative activity against SNU-638 cells. Honokiol also arrested the cell cycle progression at the G0/G1 phase and induced the apoptotic cell death in a concentration-dependent manner. The cell cycle arrest was well correlated with the downregulation of Rb, cyclin D1, cyclin A, cyclin E, and CDK4 expression, and the induction of cyclin-dependent kinase inhibitor p27. The increase of sub-G1 peak by honokiol was closely related to the induction of apoptosis, which was evidenced by the induction of DNA fragmentation, the cleavage of poly(ADPribose) polymerase, and the sequential activation of caspase cascade. These findings suggest the cell cycle arrest and induction of apoptosis might be one possible mechanism of actions for the anti-proliferative activity of honokiol in human gastric cancer cell.

Keywords

References

  1. Bai, X.H., Cerimele, F., Ushio-Fukai, M., Waqas, M., Campbell, P.M., Govindarajan, B., Der, C.J., Battle, T., Frank, D.A., Ye, K., Murad, E., Dubial, W., Soff, G., and Arbiser, J.L., Honokiol, a small molecule weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J. Biol. Chem. 278, 35501-35507 (2003).
  2. Chang, B., Lee, Y., Ku, Y., Bae, K., and Chung, C., Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms. Planta Med. 64, 367-369 (1998).
  3. Chen, F., Wang, T., Wu, Y.F., Gu, Y., Xu, X.L., Zheng, S., and Hu, X., Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J. Gastroenterol. 10, 3459-3463 (2004).
  4. Hahm, E.R., and Singh, S.V., Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol. Cancer Ther. 10, 2686-2695 (2007).
  5. Hirano, T., Gotoh, M., and Oka, K., Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci. 55, 1061-1069 (1994).
  6. Hu, H., Zhang, X.X., Wang, Y.Y., and Chen, S.Z., Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol. Sin. 26, 1063-1068 (2005).
  7. Ishitsuka, K., Hideshima, T., Hamasaki, M., Raje, N., Kumar, S., Hideshima, H., Shiraishi, N., Yasui, H., Roccaro, A.M., Richardson, P., Podar, K., Le, G..S., Gouii, S., Chauhan, D., Tamura, K., Arbiser, J., and Anderson, K.C., Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspasedependent and -independent apoptosis. Blood 106, 1794-1800 (2005).
  8. Kuribara, H., Kishi, H., Hattori, N., Okada, M., and Maruyama, Y., The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J. Pharma. Pharmacol. 52, 1425-1429 (2000).
  9. Lee, S.K., Cui, B., Mehta, R.R., Kinghorn, A.D., and Pezzuto, J.M., Cytostatic mechanism and antitumor potential of novel 1Hcyclopentea[ b]benzofuran lignans isolated from Aglaia elliptica. Chem. Biol. Interact. 115, 215-228 (1998a).
  10. Lee, S.K., Heo, Y.H., Steele, V.E., and Pezzuto, J.M., Induction of apoptosis by 1,4-phenylenebis(methylene)selenocyanate in cultured human colon cancer cells. Anticancer Res. 22, 97-102 (1998b).
  11. Li, L., Han, W., Gu, Y., Qui, S., Lu, Q., Jin, J., Luo, J., and Hu, X., Honokiol induces a necrotic cell death through the mitochondrial permeability transtion pore. Cancer Res. 67, 4894-4903 (2007).
  12. Lin, Y.R., Chen, H.H., Ko, C.H., and Chan, M.H., Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 537, 64-69 (2006).
  13. Lin, Y.R., Chen, H.H., Ko, C.H., and Chan, M.H., Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures. Neuropharmacology 49, 542-550 (2005).
  14. Miller, A.B., Berrinto, F., Hill, M., Pietinen, P., Riboli, E., and Wahrendorf, J., Diet in the etiology of cancer: a review. Eur. J. Cancer 30, 207-220 (1994).
  15. Munroe, M.E., Arbiser, J.L., and Bishop, G.A., Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol. 179, 753-763 (2007).
  16. Park, E.J., Min, H.Y., Chung, H.J., Hong, J.Y., Kang, Y.J., Hung, T.M., Youn, U.J., Kim, Y.S., Bae, K., Kang, S.S., and Lee, S.K., Downregulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett. 18, 133-140 (2009).
  17. Rouko, D.H., Current status and future perspectives in gastric cancer management. Cancer Treat. Rev. 26, 243-255 (2006).
  18. Tsugane, S., Tei, Y., Takahashi, T., Watanabe, S., and Sugano, K., Salty food intake and risk of Helicobacter pylori infection. Jpn. J. Cancer Res. 85, 474-478 (1994).
  19. Whelan, S.L., Parklin, D.M., and Masuyer, E. (eds.), Trends in Cancer Incidence and Mortality. Lyon, France, IARC Scientific Publications, 1993.
  20. Wolf, I., O'Kelly, J., Wakomoto, N., Nguyen, A., Amblard, F., Karlan, B.Y., Arbiser, J.L., and Koeffler, H.P., Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int. J. Oncol. 30, 1529-1537 (2007).
  21. Wu, Y., and Chen, J., The preventive role of diet in stomach cancer. In: Kim, J.P., Min, J.S., Mok, Y.J. (eds.), Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. Monduzzi Editore, Bologna (Italy). pp 57-63, 1999.
  22. Yang, S.E., Hsieh, M.T., Tsai, T.H., and Hsu, S.L., Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspase during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem. Pharmacol. 63, 1641-1651 (2002).
  23. Zhang, X., Chen, S., and Wang, Y., Honokiol up-regulates prostacyclin synthase protein expression and inhibits endothelial cell apoptosis. Eur. J. Pharmacol. 554, 1-7 (2007).
  24. Zhang, W.W., Li, Y., Wang, X.Q., Tian, F., Cao, H., Wang, M.W., and Sun, Q.S., Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement. World J. Gastroenterol. 11, 4414-4418 (2005).